<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35484482</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Respiratory virus detection in the upper respiratory tract of asymptomatic, community-dwelling older people.</ArticleTitle><Pagination><StartPage>411</StartPage><MedlinePgn>411</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">411</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-022-07355-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The prevalence of virus positivity in the upper respiratory tract of asymptomatic community-dwelling older people remains elusive. Our objective was to investigate the prevalence of respiratory virus PCR positivity in asymptomatic community-dwelling older people using saliva samples and nasopharyngeal and oropharyngeal swabs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed 504 community-dwelling adults aged&#x2009;&#x2265;&#x2009;65&#x2009;years who were ambulatory and enrolled in a cross-sectional study conducted from February to December 2018 in Nagasaki city, Japan. Fourteen respiratory viruses were identified in saliva, nasopharyngeal and oropharyngeal samples using multiplex PCR assays.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalences of PCR positivity for rhinovirus, influenza A, enterovirus and any respiratory virus were 12.9% (95% CI: 10.1-16.1%), 7.1% (95% CI: 5.1-9.8%), 6.9% (95% CI: 4.9-9.5%) and 25.2% (95% CI: 21.5-29.2%), respectively. Rhinovirus was detected in 21.5% of subjects, influenza A in 38.9% of subjects, enterovirus in 51.4% of subjects and any virus in 32.3% of subjects using only saliva sampling.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalences of several respiratory viruses were higher than the percentages reported previously in pharyngeal samples from younger adults. Saliva sampling is a potentially useful method for respiratory virus detection in asymptomatic populations.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yasuda</LastName><ForeName>Ikkoh</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Internal Medicine and Infectious Diseases, Kita-Fukushima Medical Center, Fukushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Motoi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Haruka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terada</LastName><ForeName>Mayumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nijigaoka Hospital, Nagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sando</LastName><ForeName>Eiichiro</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Internal Medicine and Infectious Diseases, Kita-Fukushima Medical Center, Fukushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Chris Fook Sheng</ForeName><Initials>CFS</Initials><AffiliationInfo><Affiliation>Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otomaru</LastName><ForeName>Hirono</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Lay-Myint</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimoto</LastName><ForeName>Konosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. komorimo@nagasaki-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Infections, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. komorimo@nagasaki-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nijigaoka Hospital, Nagasaki, Japan. komorimo@nagasaki-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057187" MajorTopicYN="N">Independent Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="N">Multiplex Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asymptomatic</Keyword><Keyword MajorTopicYN="N">Community-dwelling</Keyword><Keyword MajorTopicYN="N">Older people</Keyword><Keyword MajorTopicYN="N">Polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Respiratory virus</Keyword></KeywordList><CoiStatement>KM reports receiving speaker fees from Kyorin Pharma and MSD within three years. The salaries of KM and HM are paid by the collaboration project of Nagasaki University and Pfizer Inc. All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35484482</ArticleId><ArticleId IdType="pmc">PMC9047617</ArticleId><ArticleId IdType="doi">10.1186/s12879-022-07355-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-022-07355-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angeles Marcos M, Camps M, Pumarola T, Antonio Martinez J, Martinez E, Mensa J, Garcia E, Penarroja G, Dambrava P, Casas I, et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther. 2006;11(3):351&#x2013;359. doi: 10.1177/135965350601100306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/135965350601100306</ArticleId><ArticleId IdType="pubmed">16759052</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings LC, Anderson TP, Beynon KA, Chua A, Laing RT, Werno AM, Young SA, Chambers ST, Murdoch DR. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63(1):42&#x2013;48. doi: 10.1136/thx.2006.075077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.075077</ArticleId><ArticleId IdType="pubmed">17573440</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsurada N, Suzuki M, Aoshima M, Yaegashi M, Ishifuji T, Asoh N, Hamashige N, Abe M, Ariyoshi K, Morimoto K, et al. The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study. BMC Infect Dis. 2017;17(1):755. doi: 10.1186/s12879-017-2858-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2858-y</ArticleId><ArticleId IdType="pmc">PMC5719746</ArticleId><ArticleId IdType="pubmed">29212450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A, Shtainberg R, Lieberman D. Respiratory viruses in adults with community-acquired pneumonia. Chest. 2010;138(4):811&#x2013;816. doi: 10.1378/chest.09-2717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-2717</ArticleId><ArticleId IdType="pmc">PMC7094496</ArticleId><ArticleId IdType="pubmed">20363845</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger R, Morita H, Comito D, Filip I, Galanti M, Lane B, Ligon C, Rosenbloom D, Shittu A, Ud-Dean M, et al. Asymptomatic shedding of respiratory virus among an ambulatory population across seasons. mSphere. 2018 doi: 10.1128/mSphere.00249-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00249-18</ArticleId><ArticleId IdType="pmc">PMC6041500</ArticleId><ArticleId IdType="pubmed">29997120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundell N, Andersson LM, Brittain-Long R, Sundvall PD, Alsio A, Lindh M, Gustavsson L, Westin J. PCR&#xa0;Detection of respiratory pathogens in asymptomatic and symptomatic adults. J Clin Microbiol 2019.&#xa0;10.1128/JCM.00716-18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322459</ArticleId><ArticleId IdType="pubmed">30355759</ArticleId></ArticleIdList></Reference><Reference><Citation>Loens K, Van Heirstraeten L, Malhotra-Kumar S, Goossens H, Ieven M. Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol. 2009;47(1):21&#x2013;31. doi: 10.1128/JCM.02037-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02037-08</ArticleId><ArticleId IdType="pmc">PMC2620840</ArticleId><ArticleId IdType="pubmed">19020070</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, Leung WS, Chik TS, Choi CY, Kandamby DH, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;71(15):841&#x2013;843. doi: 10.1093/cid/ciaa149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa149</ArticleId><ArticleId IdType="pmc">PMC7108139</ArticleId><ArticleId IdType="pubmed">32047895</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ, et al. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N Engl J Med. 2020;383:1283&#x2013;1286. doi: 10.1056/NEJMc2016359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2016359</ArticleId><ArticleId IdType="pmc">PMC7484747</ArticleId><ArticleId IdType="pubmed">32857487</ArticleId></ArticleIdList></Reference><Reference><Citation>Caulley L, Corsten M, Eapen L, Whelan J, Angel JB, Antonation K, Bastien N, Poliquin G, Johnson-Obaseki S. Salivary detection of COVID-19. Ann Intern Med. 2020;174(1):131&#x2013;133. doi: 10.7326/M20-4738.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4738</ArticleId><ArticleId IdType="pmc">PMC7470212</ArticleId><ArticleId IdType="pubmed">32857591</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565&#x2013;574. doi: 10.1016/S1473-3099(20)30196-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30196-1</ArticleId><ArticleId IdType="pmc">PMC7158907</ArticleId><ArticleId IdType="pubmed">32213337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YG, Yun SG, Kim MY, Park K, Cho CH, Yoon SY, Nam MH, Lee CK, Cho YJ, Lim CS. Comparison between saliva and nasopharyngeal swab specimens for detection of respiratory viruses by multiplex reverse transcription-PCR. J Clin Microbiol. 2017;55(1):226&#x2013;233. doi: 10.1128/JCM.01704-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01704-16</ArticleId><ArticleId IdType="pmc">PMC5228234</ArticleId><ArticleId IdType="pubmed">27807150</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda I, Suzuki M, Dhoubhadel BG, Terada M, Satoh A, Sando E, Hiraoka T, Kurihara M, Matsusaka N, Kawahara F, et al. The low carriage prevalence of pneumococcus among community-dwelling older people: a cross-sectional study in Japan. Vaccine. 2020;38(21):3752&#x2013;3758. doi: 10.1016/j.vaccine.2020.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.03.033</ArticleId><ArticleId IdType="pubmed">32265047</ArticleId></ArticleIdList></Reference><Reference><Citation>Grijalva CG, Griffin MR, Edwards KM, Johnson M, Gil AI, Verastegui H, Lanata CF, Williams JV. Concordance between RT-PCR-based detection of respiratory viruses from nasal swabs collected for viral testing and nasopharyngeal swabs collected for bacterial testing. J Clin Virol. 2014;60(3):309&#x2013;312. doi: 10.1016/j.jcv.2014.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.04.011</ArticleId><ArticleId IdType="pmc">PMC4055503</ArticleId><ArticleId IdType="pubmed">24875136</ArticleId></ArticleIdList></Reference><Reference><Citation>Product catalog of Eiken Chemical Co. htttp://bookshelf.wisebook4.jp/html/eiken03100/10958/#16.&#xa0; Accessed 1 Mar&#xa0;2022.</Citation></Reference><Reference><Citation>Yoshida LM, Suzuki M, Yamamoto T, Nguyen HA, Nguyen CD, Nguyen AT, Oishi K, Vu TD, Le TH, Le MQ, et al. Viral pathogens associated with acute respiratory infections in central vietnamese children. Pediatr Infect Dis J. 2010;29(1):75&#x2013;77. doi: 10.1097/INF.0b013e3181af61e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181af61e9</ArticleId><ArticleId IdType="pubmed">19907358</ArticleId></ArticleIdList></Reference><Reference><Citation>Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, Hymas WC, Stockmann C, Bramley AM, Schneider E, et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis. 2016;213(4):584&#x2013;591. doi: 10.1093/infdis/jiv323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv323</ArticleId><ArticleId IdType="pmc">PMC4721902</ArticleId><ArticleId IdType="pubmed">26180044</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Lu L, Yip CC, Poon RW, Fung AM, Cheng A, Lui DH, Ho DT, Hung IF, Chan KH, et al. Additional molecular testing of saliva specimens improves the detection of respiratory viruses. Emerg Microbes Infect. 2017;6(6):e49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520312</ArticleId><ArticleId IdType="pubmed">28588283</ArticleId></ArticleIdList></Reference><Reference><Citation>To KKW, Yip CCY, Lai CYW, Wong CKH, Ho DTY, Pang PKP, Ng ACK, Leung KH, Poon RWS, Chan KH, et al. Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect. 2019;25(3):372&#x2013;378. doi: 10.1016/j.cmi.2018.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2018.06.009</ArticleId><ArticleId IdType="pubmed">29906597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177&#x2013;1179. doi: 10.1056/NEJMc2001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal AJ, Mozafarihashjin M, Coomes E, Powis J, Li AX, Paterson A, Anceva-Sami S, Barati S, Crowl G, Faheem A, et al. Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2. Clin Infect Dis. 2021;72(6):1064&#x2013;1066. doi: 10.1093/cid/ciaa848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa848</ArticleId><ArticleId IdType="pmc">PMC7337630</ArticleId><ArticleId IdType="pubmed">32584972</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vinh Chau N, Lam VT, Dung NT, Yen LM, Minh NNQ, Hung LM, Ngoc NM, Dung NT, Man DNH, Nguyet LA, et al. The natural history and transmission potential of asymptomatic severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2020;71(10):2679&#x2013;2687. doi: 10.1093/cid/ciaa711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa711</ArticleId><ArticleId IdType="pmc">PMC7314145</ArticleId><ArticleId IdType="pubmed">32497212</ArticleId></ArticleIdList></Reference><Reference><Citation>Congrave-Wilson Z, Lee Y, Jumarang J, Perez S, Bender JM, Bard JD, Pannaraj PS. Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection. JAMA. 2021;326(11):1065&#x2013;1067. doi: 10.1001/jama.2021.13967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.13967</ArticleId><ArticleId IdType="pmc">PMC8456387</ArticleId><ArticleId IdType="pubmed">34387653</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>